The objective of this paper is to describe the data collected by the CBVCT services from the Community-based testing (COBATEST) network, from 2014 to 2016, in order to provide an insight into community-based voluntary counselling and testing (CBVCT) services' testing activity in Europe.
Introduction
Although HIV can be prevented through effective public health measures, HIV transmission continues in Europe. In 2015, 29 747 people were diagnosed with HIV in the 31 countries of the EU/EEA, with a rate of 6.3 per 100 000 [1] .
Early diagnosis is beneficial both to the infected individual, allowing for early treatment, and in preventing onward HIV transmission [1] [2] [3] . However, late presentation remains high in Europe; 47% of people diagnosed with HIV have a CD4 cell count of less than 350 cell/mm 3 and 28%
are diagnosed with advanced HIV infection (CD4 < 200 cells/mm 3 ) [1] . Moreover, 15% of people living with HIV (PLWH) are unaware of their infection. [1, 4] . The HIV care continuum is an internationally-recognized framework that models the dynamic stages of HIV care from testing to suppression of the virus [5] . In order to measure the HIV care continuum in Europe, it has been recommended to measure four stages according to the 90-90-90 targets advocated by the Joint United Nations Programme on HIV/AIDS (UNAIDS) [6] : number of PLWH, number/proportion diagnosed, number/ proportion on ART, and number/proportion virally suppressed [7] .
In order to reach the 90-90-90 targets, the first step (by 2020, 90% of all people living with HIV will know their HIV status) is critical [8] . Nevertheless, testing rates among key populations are below 50% in many EU countries [9] . New strategies are required to expand targeted HIV testing services, focusing on reaching the most affected population groups in the local and national epidemic context [1] . Community-based voluntary counselling and testing (CBVCT) services have been recognized as a good model to improve access to HIV testing for key populations [10] .
The Community-based testing (COBATEST) network is a network of CBVCT services, established in the framework of the European project HIV Community-Based Testing Practices in Europe (HIV-COBATEST) [11] . The objective of this paper is to describe the data collected during the period 2014-2016 by the CBVCT services from the COBATEST network that are using the common tools, in order to provide an insight into CBVCT services' testing activity in Europe.
Methods
The CBVCT services in the COBATEST network were heterogeneous in terms of size and capacity and in terms of the key populations they attend. Some of them were targeting men who have sex with men (MSM), people who inject drugs (PWID) or sex workers (SW), and others were attending the general population or a mix of key populations.
The COBATEST network developed standard data collection instruments and procedures to homogenize the monitoring and evaluation of HIV testing activities at the community level: a standardized data collection form, a web-based data entry tool and a list of core CBVCT indicators to monitor and evaluate HIV testing activity) [12, 13] .
The CBVCT centres which are members of the network can submit their data in three different ways: using the COBATEST tools for data collection and data entry; in disaggregated form according to data file specifications (variable and format descriptions) to calculate the COBATEST indicators; in an aggregated form with the COBATEST indicators already calculated.
For this study, a descriptive analysis of HIV testing activity of CBVCT services in the COBATEST network that were using the COBATEST common tools was performed for the period January 1st 2014-to December 31st 2016.
The standardised data collection form included questions related to socio-demographic characteristics (gender, date and country of birth), reasons for testing, risk-behaviours (sexual partners, condom use, sexual work, intravenous drug use), HIV testing history, HIV testing results and confirmation and linkage to care. Those using the COBATEST data collection form entered the data into a centralized database that allowed analysis of pooled data from all participating centres using the common tools. CBVCT services use a unique Client Identification Code that ensured the anonymity of the client and allowed the identification of repeat testers.
The descriptive analysis was performed on pooled data and the sample's distribution and the percentage of people with a reactive screening test according to the following variables is presented: gender [men, women, transgender (defined with one question about gender identity)], age, foreign nationals (defined as been born in a country different to the country where the CBVCT service is placed), transmission groups [constructed as hierarchical, mutually exclusive risk categories: people who inject drugs (PWID), male sex workers (MSW), men who have sex with men (MSM), female sex worker (FSW), heterosexual women (HW), heterosexual men (HM)], type of test [rapid oral HIV test, rapid blood HIV test, conventional test (Elisa)], testing sites (CBVCT office, and a list of different outreach activities) and HIV testing history [first time testers (those tested for first time in their lives), repeat testers (those tested more than once in their lives)]. Those with a reactive screening test and a previous HIV positive result were eliminated from the analysis, unless the confirmation and linkage to care were done for the first time through the CBVCT service.
Key indicators for HIV testing activity were analyzed: number and percentage of tests performed, clients tested, reactive screening tests, confirmatory tests performed, confirmed positive results and confirmed positive results linked to care. Confirmatory tests were not part of the CBVCT's standard service, so the clients with a reactive screening test were referred to a laboratory or to a clinic for the confirmatory test. Linkage to care was defined as "percentage of people with a reactive screening test that had contact with specialist HIV care". Data analysis was performed using PASW Statistics for Windows, version 18.0.
Results
In 2014, 20 CBVCT centres from the COBATEST network used the common data collection tools, increasing to 25 in 2015 and 29 in 2016. The total number of tests performed during the study period increased 19.3%, and more CBVCT sites were included in the analyses as they began to use the COBAT-EST common tools. The percentage of confirmatory tests performed and the percentage of reactive screening tests that were linked to care have improved over the study period, increasing from 63.0% to 90.0% and from 43.0% to 79.9%, respectively.
Most of the tested individuals were men (70.5%) aged between 21 and 35 years (57.2%) and non-foreign born (66.8%). A higher proportion of individuals tested were MSM (44.7%, including MSW) compared to HM (23.8%) and HW (22.3%). Rapid tests were used in 98.1% of cases (73.9% rapid blood tests; 24.2% rapid oral tests), and were mostly performed in CBVCT offices (88.3%). HIV testing in outreach activities represents just 11.7% of the total tests performed, but reaches a higher proportion of key groups (20.1% of PWID, 7.5% of MSW, 11.9% of MSM, and 13.3% of FSW).
Of the total number of tested individuals, 35.1% were new testers (Table 2) . Those new testers are mainly men (62.8%), non-foreign born (70.4%), between 21 and 35 years old (60.1%), and regarding transmission group, mainly HM (34.5%) and HW (34.3). A lower proportion of first-time testers are MSM (24.4%).
The percentage of reactive screening tests (Table 2 ) was particularly high among transgender people, with an overall percentage of 8.4% (this percentage has decreased over years, from 9.6% to 6.8%). Those considered foreigners have a higher percentage of reactive screening tests (2.3%) compared to non-foreign born (1.4%).
Regarding the transmission group, the highest percentage of reactive screening tests is for MSW with an overall percentage of 6.4% (decreasing from 7.8% in 2014 to 5.7% in 2016), followed by PWID with an overall percentage of 3.3% (ranging from 0.7% in 2014 to 9.1% in 2016) and MSM with a percentage of 2.8% (ranging between 2.6-2.9%). Transgender people were mainly included in the transmission group of MSW and MSM, according to their risk behaviours.
Repeat testers had a higher percentage of reactive tests (2.0%) than those tested for the first time (1.1%).
Discussion
Our results, together with other studies [10, 14] , indicate that CBVCT services are successful in diagnosing previously undiagnosed HIV infected individuals in key populations, especially among MSM and MSW, transgender people and PWID.
The data analyzed show that people accessing CBVCT services in the COBATEST network are mostly MSM, between 21 and 35 years old and non-foreign born. Although the pooled prevalence estimate was not very high (1.6%), the prevalence estimate among specific groups such as transgender people (8.4%), MSM (2.8%) and MSW (6.4%) were much higher than other gender and transmission groups. We have to take into account that most of the transgender of the sample, according to their risks behaviours, are included in the transmission group of MSW, and the remaining in the MSM group. Although CBVCT services are mainly targeting MSM, more prevention work has to be done with the aforementioned groups in order to increase HIV testing uptake and frequency. The CBVCT services are effective at improving access to testing in key populations [10, 14] but more effort must be made to reach those that are not attending the CBVCT services. This can be achieved by increasing outreach activities (Only 11.7% of tests were performed in outreach, but this testing reached 20.1% of the total PWID tested, 13.3% of the total FSW and 11.9% of the total MSM) and implementing specific programmes addressed to these groups [15] . PWID have a high overall percentage of reactive screening tests (3.3%), but this varies widely over the period of study (ranging from 0.8% to 9.1%) due to the low number of PWID tested. Among the COBATEST sites using the common tools, only two are aimed at the PWID population specifically. The performance indicators in Table 1 are key for evaluating the HIV testing activity in CBVCT sites and its relevance at the public health level [16] . It is crucial to know the number of tests performed and HIV prevalence among the tested to assess if we are reaching the first 90-90-90 objective. The indicators are also important to allow CBVCT services to evaluate the effectiveness of their model. This study showed an increase in the proportion of linkage to care in individuals with reactive screening tests and positive confirmatory tests. Despite this promising finding there is still room for improvement, particularly in guaranteeing confirmatory tests for those with a reactive screening test [7, 16, 17] .
Our results found a high percentage of first-time testers (35.4%), showing the great potential of CBVCT services to reach people who have never before been tested. Those first-time testers are mainly men, young, heterosexual and non-foreign born, but a non-negligible percentage are MSM (24.4%), and foreign born (29.6%). It is important that once the CBVCT service has reached those new testers, they also use the opportunity to encourage a regular HIV testing routine. An important limitation of this study is that the analysis was conducted in CBVCT centres which are members of the COBATEST network and use common tools. Results are therefore not generalisable to all CBVCT services in Europe, and are not representative at the national or European level.
The information collected through the CBVCT services strengthens the case for community-based service delivery models as an integral part of the HIV strategic investments. The data is an important source of information to ensure quality services along the HIV care cascade [17] .
The COBATEST network and the analysis of the monitoring and evaluation indicators collected will be crucial in selecting which CBVCT indicators should be included in the Dublin Declaration monitoring process [18] which measures the progress of the HIV response of each country, allowing better assessment of the HIV care cascade and improving the effectiveness of CBVCT services across Europe.
In conclusion, the monitoring and evaluation results from the COBATEST network prove the feasibility of collecting standardized data from CBVCT services in different countries across Europe, as well as demonstrating the usefulness of such data.
